Paper · 36967464
Insulin Resistance Indices and Carotid Intima-media Thickness in Physically Fit Adults: CHIEF Atherosclerosis Study.
Lin YP and 4 others. Endocr Metab Immune Disord Drug Targets, 2023. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Insulin Resistance Indices and Carotid Intima-media Thickness in Physically Fit Adults: CHIEF Atherosclerosis Study. Papers, record 36967464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36967464
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Insulin Resistance Indices and Carotid Intima-media Thickness in Physically Fit Adults: CHIEF Atherosclerosis Study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin Resistance | Major topic |
| Hyperuricemia | Major topic |
| Atherosclerosis | Major topic |
| Young Adult | |
| Humans | |
| Middle Aged | |
| Carotid Intima-Media Thickness | |
| Insulin | |
| Triglycerides | |
| Obesity | |
| Cholesterol, HDL | |
| Glucose | |
| Risk Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,839,237 | Triglyceride-glucose index as a cardiovascular risk marker: updated evidence, limitations, and future perspectives. | Lipids Health Dis | 2026 | https://conductscience.org/library/papers/42839237 | PubMed |
| 42,539,781 | Review on the Relationship Between TyG Index and CVD Incidence in Patients With T2DM With NAFLD. | Int J Endocrinol | 2026 | https://conductscience.org/library/papers/42539781 | PubMed |
| 42,220,054 | Association of triglyceride-driven residual atherosclerotic risk with carotid stiffening assessed using ultrafast ultrasound imaging in individuals with hypertriglyceridemia. | Ultrasonography | 2026 | https://conductscience.org/library/papers/42220054 | PubMed |
| 41,113,474 | Early predictors of carotid atherosclerosis in patients with type 2 diabetes mellitus. | World J Diabetes | 2025 | https://conductscience.org/library/papers/41113474 | PubMed |
| 40,918,187 | Mental stress and the risks of metabolic syndrome and related components in military personnel: CHIEF cohort study. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40918187 | PubMed |
| 40,859,224 | The triglyceride-glucose index: updating evidence from clinical settings to molecular mechanisms in ageing-related cerebrovascular diseases. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40859224 | PubMed |
| 40,268,830 | Association Between Carotid Intima-Media Thickness and Novel Lipid Parameters in Hypertensive Patients. | High Blood Press Cardiovasc Prev | 2025 | https://conductscience.org/library/papers/40268830 | PubMed |
| 39,649,228 | Association between various insulin resistance indices and cardiovascular disease in middle-aged and elderly individuals: evidence from two prospectives nationwide cohort surveys. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39649228 | PubMed |
| 38,828,124 | Associations between insulin resistance indices and subclinical atherosclerosis: A contemporary review. | Am J Prev Cardiol | 2024 | https://conductscience.org/library/papers/38828124 | PubMed |
| 38,664,804 | Prediction of various insulin resistance indices for the risk of hypertension among military young adults: the CHIEF cohort study, 2014-2020. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/38664804 | PubMed |
1 to 10 of 13
See all 13 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CIMT | 404,677 | PubTator's text mining | https://conductscience.org/library/genes/404677 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36967464
GET https://conductscience.org/api/papers/v1/36967464/authors